Lita A Freeman Selected Research

Lita A Freeman Research Topics

Disease

12	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 01/2024 - 01/2016
7	Atherosclerosis 01/2020 - 11/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2018
2	Cholestasis 08/2022 - 01/2020
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 01/2022
2	Acute Coronary Syndrome 01/2020 - 07/2018
2	Coronary Disease (Coronary Heart Disease) 11/2018 - 01/2016
2	Hypertriglyceridemia 12/2017 - 02/2016
2	Anemia 01/2017 - 03/2016
1	Liver Diseases (Liver Disease) 01/2024
1	Hemolysis 01/2024
1	Neoplasms (Cancer) 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023
1	Lymphocytosis 01/2023
1	Hypercholesterolemia 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Hyperbilirubinemia 01/2020
1	Intrahepatic Cholestasis 01/2020
1	Proteinuria 01/2019
1	Obesity 01/2019
1	Disease Progression 01/2019
1	Inflammation (Inflammations) 11/2016
1	Corneal Opacity 03/2016
1	Nephrosis 01/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2015
1	Autoimmune Lymphoproliferative Syndrome 01/2015
1	Dyslipidemias (Dyslipidemia) 01/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015
1	Psoriatic Arthritis 01/2015
1	Overweight 10/2012
1	Weight Loss (Weight Reduction) 10/2012

Drug/Important Bio-Agent (IBA)

12	CholesterolIBA 01/2024 - 11/2006
10	Lipoproteins (Lipoprotein)IBA 01/2024 - 11/2006
7	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 01/2020 - 01/2016
6	HDL CholesterolIBA 01/2023 - 10/2012
5	LipidsIBA 01/2023 - 11/2006
4	Lipoprotein-XIBA 01/2024 - 01/2016
4	HDL LipoproteinsIBA 01/2023 - 10/2012
3	oxidized low density lipoproteinIBA 01/2022 - 10/2012
2	ApolipoproteinsIBA 01/2023 - 01/2017
2	EnzymesIBA 01/2019 - 03/2016
2	Peptides (Polypeptides)IBA 01/2018 - 02/2016
2	Apolipoprotein C-II (ApoC2)IBA 12/2017 - 02/2016
2	CytokinesIBA 11/2016 - 01/2016
2	LDL CholesterolIBA 01/2015 - 10/2012
1	BilirubinIBA 01/2024
1	Hemoglobins (Hemoglobin)IBA 01/2024
1	IntegrinsIBA 01/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023
1	Integrin alpha4beta1 (VLA-4)IBA 01/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	acalabrutinibIBA 01/2023
1	phosphatidylethanolamineIBA 01/2023
1	Proprotein Convertase 9IBA 01/2022
1	LDL Receptors (LDL Receptor)IBA 01/2022
1	LecithinsIBA 01/2020
1	Alkaline PhosphataseIBA 01/2020
1	1-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA 01/2020
1	Filipin (Filipin III)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	PolymersIBA 01/2017
1	Cholesterol Esters (Cholesteryl Esters)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	CyclodextrinsIBA 01/2017
1	InflammasomesIBA 11/2016
1	Apolipoproteins C (ApoC)IBA 02/2016
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2015
1	Interleukin-10 (Interleukin 10)IBA 01/2015
1	SterolsIBA 01/2007
1	Apolipoproteins B (ApoB)IBA 01/2007
1	Ezetimibe (Zetia)FDA Link 01/2007

Therapy/Procedure

6	Therapeutics 01/2023 - 02/2016
3	Enzyme Replacement Therapy 01/2020 - 07/2018